Clark Capital Management Group »

Royalty Pharma shares owned by Clark Capital Management Group

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Clark Capital Management Group from 13F filings

Historical chart of Clark Capital Management Group investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Clark Capital Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Clark Capital Management Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $62M 1.8M 35.28

More positions owned by Clark Capital Management Group

Ishares Tr Iboxx Hi Yd Etf (HYG)
Spdr Series Trust Portfolio S&p500 (SPLG)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Spdr Series Trust Bloomberg High Y (JNK)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Total (IXUS)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Nvent Electric SHS (NVT)
Johnson & Johnson (JNJ)
Abbvie (ABBV)

View all positions for Clark Capital Management Group

Top funds holding Royalty Pharma

Morgan Stanley
FMR
Capital Research and Management Company - Division 3
BlackRock
Baillie Gifford & Co
Swedbank AB
Adage Capital Partners GP
Vanguard Group
State Street Corporation
Geode Capital Management
Caledonia
Victory Capital Management
Northern Trust
Jane Street
Arrowstreet Capital, Limited Partnership

View all funds holding Royalty Pharma